Muhammed Kılınç1, Ender Ayvat1, Özge Onursal Kılınç1, Fatma Ayvat1, Mert Doğan2, Gülşah Sütçü Uçmak2, Can Ebru Bekircan Kurt3, Sevim Erdem Özdamar3, Sibel Aksu Yıldırım1, Ersin Tan3

1Department of Neurological Physiotherapy and Rehabilitation, Hacettepe University Faculty of Physical Therapy and Rehabilitation, Ankara, Türkiye
2Department of Physiotherapy and Rehabilitation, Akdeniz University Faculty of Health Sciences, Antalya, Türkiye
3Department of Neurology, Hacettepe University Faculty of Medicine, Ankara, Türkiye

Keywords: COVID-19, neuromuscular disease, pandemic.

Abstract

Objectives: The study aimed to examine the pandemic-related attitudes and behaviors of adult individuals with neuromuscular disease during the coronavirus disease 2019 (COVID-19) pandemic.

Patients and methods: A total of 87 individuals (55 males, 32 females; mean age: 39.7±14.5 years; range, 19 to 80 years) with neuromuscular disease were included in the cross-sectional study between July 2022 and December 2022. After obtaining the demographic information of the individuals, information about neuromuscular disease and COVID-19, vaccination status, and their situation during the pandemic were questioned with yes/no or open-ended questions.

Results: While the most prevalent neuromuscular disease was spinal muscular atrophy (n=30, 34.5%), 72 (82.8%) individuals had no comorbities. Twenty-nine (33.3%) individuals had COVID-19, and seven (24.1%) of these individuals had COVID-19 with high severity. Eighty-two (94.3%) individuals were vaccinated. Among the individuals who had COVID-19, 10 (34.5%) individuals stated that their physical condition was worse than before the pandemic. Among the whole participants, 40 (48.3%) individuals stated that it was worse and much worse. Only 15 (17.2%) individuals continued to participate in physical therapy practices during the pandemic period. Forty-three (49.4%) individuals said that their social life was worse and much worse than before the pandemic.

Conclusion: The course of COVID-19 in individuals with neuromuscular disorders may not be as severe as expected. Further studies are needed to generalize these findings to the broader neuromuscular disease population.

Cite this article as: Kılınç M, Ayvat E, Onursal Kılınç Ö, Ayvat F, Doğan M, Sütçü Uçmak G, et al. The impact of COVID-19 pandemic on adult individuals with neuromuscular disease. Turk J Neurol 2025;31(3):294-300. doi: 10.55697/tnd.2025.358.